Rocket Pharmaceuticals News and Activities

Rocket Pharmaceuticals is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Rocket Pharmaceuticals is a company listed under the stock ticker RCKT (US).

Acquisition, funding and merger involving Rocket Pharmaceuticals.

• Rocket Pharmaceuticals has just announced a $180 Million fundraising (posted on June 18 2026).

View the org chart displaying its 14 main executives

Most searched biographies at Rocket Pharmaceuticals

• Gaurav Shah, Chief Executive Officer and President
• Carsten Boess, Independent Director
• Roderick Wong, Chairman of the Board

Popular executive movements at Rocket Pharmaceuticals

• John Militello, Vice President and Principal Accounting Officer, has left the company  (posted on July 1 2026).
• Joseph Manhede has joined the company as Principal Accounting Officer  (posted on July 1 2026).

Create your alert
to follow the executive moves at Rocket Pharmaceuticals.

Rocket Pharmaceuticals has 1,920 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Vertex Pharmaceuticals has announced the acquisition of Crinetics Pharmaceuticals  (posted on July 7 2026).
• Novartis has announced the acquisition of Myricx Bio  (posted on July 6 2026).
• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

Popular contacts in Pharmaceuticals

• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry

Press releases by Rocket Pharmaceuticals

• Rocket Pharmaceuticals Appoints Mayo Pujols as Chief Technical Officer and Strengthens Manufacturing Capabilities | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals to Present at William Blair Biotech Focus Conference | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals Presents Positive Clinical Data from Danon Disease, Fanconi Anemia and Pyruvate Kinase Deficiency Programs at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals to Present at UBS Global Healthcare Conference | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Progress | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals to Present at the Bank of America Securities 2022 Global Healthcare Conference | Rocket Pharmaceuticals, Inc.
• View more press releases Close

Social media about Rocket Pharmaceuticals

• Rocket Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Rocket Pharmaceuticals on LinkedIn, X (Twitter) & YouTube